The content of lactoferrin and interleukin-8 in breast milk of patients with lactational mastitis

Skrócona strona pozycji
dc.contributor.authorDemianchuk, Nataliia
dc.contributor.authorAkimova, Viorika
dc.contributor.authorSoyka, Larysa
dc.contributor.authorShchurko, Mariia
dc.contributor.authorLapovets, Lyubov
dc.contributor.authorLutsiv, Nataliia
dc.contributor.authorTkachuk, Serhii
dc.contributor.authorBuchko, Olha
dc.contributor.authorZubchenko, Svitlana
dc.contributor.authorHayduchok, Ihor
dc.date.accessioned2024-03-28T19:46:36Z
dc.date.available2024-03-28T19:46:36Z
dc.date.issued2024-03
dc.descriptionAll subjects gave their informed consent for inclusion before they participated in the study. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of Danylo Halytski Lviv National Medical University, Ukraine (meeting minutes No. 2 dated February 15, 2016).
dc.description.abstractIntroduction and aim. Information concerning lactoferrin and interleukin-8 (IL-8) local levels in breast milk are not numerous and requires further research. The aim of this study was to determine the content of lactoferrin and interleukin-8 in the breast milk of patients with lactational mastitis, and to identify new potential markers for assessing the activity of the inflammatory process in the mammary gland. Material and methods. This study analyzed the breast milk of 30 women with lactostasis (group I), 37 women with lactational mastitis (group II) and 30 healthy lactating women (age 26±5 years old). The milk content of lactoferrin and interleukin-8 (IL-8) was determined by enzyme-linked immunosorbent assay. Results. The average value of lactoferrin in breast milk of healthy women was 4.78±0.47 mg/mL, exceeding levels in group I 1.8 times (p<0.05). The level of lactoferrin in group II exceeds the control values 3.1 times (p<0.05). The content of IL-8 in breast milk of women in group I was 7.3 times higher than the control (3.63±0.12 pg/mL, p<0.05). In lactational mastitis, the concentration of IL-8 in breast milk exceeded the group I 13.9 times (p<0.05) and was 1.9 times higher than group I (p<0.05). Conclusion. The analysis has revealed an increase of lactoferrin and IL-8 in breast milk of the test groups, which indicates the activation of non-specific protection.eng
dc.identifier.citationEuropean Journal of Clinical and Experimental Medicine T. 22, z. 1 (2024), s. 117–120
dc.identifier.doi10.15584/ejcem.2024.1.22
dc.identifier.eissn2544-1361
dc.identifier.urihttps://repozytorium.ur.edu.pl/handle/item/10365
dc.language.isoeng
dc.publisherPublishing Office of the University of Rzeszow
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Poland*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/pl/*
dc.subjectbreast milk
dc.subjectinterleukin-8
dc.subjectlactational mastitis
dc.subjectlactoferrin
dc.subjectlactostasis
dc.titleThe content of lactoferrin and interleukin-8 in breast milk of patients with lactational mastitis
dc.typearticle
Pliki
Oryginalny pakiet
Aktualnie wyświetlane 1 - 1 z 1
Obrazek miniatury
Nazwa:
15.the_content_of_lactoferrin_and_interleukin-8_in_breast_milk.pdf
Rozmiar:
179.21 KB
Format:
Adobe Portable Document Format
Opis:
Pobierz
Pakiet licencji
Aktualnie wyświetlane 1 - 1 z 1
Obrazek miniatury
Nazwa:
license.txt
Rozmiar:
1.28 KB
Format:
Item-specific license agreed upon to submission
Opis:
Pobierz
Kolekcje
European Journal of Clinical and Experimental Medicine T.22, z. 1 (2024)